CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most lethal subtype of breast cancer due to its lack of treatment options. Patients with TNBC frequently develop resistance to chemotherapy. As epigenetic-based antineoplastic drugs, histone deacetylase inhibitors (HDACis) have achieved particular efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xin-le, Du, Jun, Zheng, Ya-dan, Dai, Jia-jing, Lin, Su-wen, Zhang, Bing-yue, Zhong, Fu-bo, Lin, Zhe-guang, Jiang, Shu-qi, Wei, Wei, Fang, Zheng-yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075662/
https://www.ncbi.nlm.nih.gov/pubmed/33959656
http://dx.doi.org/10.1155/2021/5089371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075662/
https://www.ncbi.nlm.nih.gov/pubmed/33959656
http://dx.doi.org/10.1155/2021/5089371

Ejemplares similares